These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4349819)

  • 21. Use of cell cultures in vaccine production: diploid and stable cell cultures.
    Matchett A
    J Am Vet Med Assoc; 1970 Jun; 156(12):1791-4. PubMed ID: 4987214
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on Japanese B encephalitis virus vaccine from tissue culture. VI. Development of a hamster kidney tissue culture inactivated vaccine for man. 4. Preparation and characterization of vaccine lot for human trial.
    Darwish MA; Hammon WM
    Am J Trop Med Hyg; 1966 Sep; 15(5):765-8. PubMed ID: 4288193
    [No Abstract]   [Full Text] [Related]  

  • 23. Serially subcultivated cells as substrates for poliovirus production for vaccine.
    von Seefried A; Chun JH
    Dev Biol Stand; 1981; 47():25-33. PubMed ID: 6262151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aluminum-marker of wild type 1 poliovirus strains.
    Nakao C; Tagaya I; Komatsu T; Kodama H
    Jpn J Microbiol; 1970 Sep; 14(5):405-12. PubMed ID: 4319729
    [No Abstract]   [Full Text] [Related]  

  • 25. [Plaque formation by poliovirus cultivated in monkey kidney culture on a methylcellulose containing medium].
    Hövel H; Günther O
    Zentralbl Bakteriol Orig; 1964 Dec; 195(2):149-56. PubMed ID: 4284126
    [No Abstract]   [Full Text] [Related]  

  • 26. [Studies on safety tests of inactivated poliomyelitis vaccines. V. Pathomorphological changes in the CNS of rhesus monkeys (Macaca rhesus) and long-tailed monkeys (Cercopithecus aethiops) following intracerebral and intralumbar inoculation with inactivated poliovirus types I, II, and 3].
    Unterharnscheidt F; Günther O; Hövel H; Burde K; Heber L
    Zentralbl Bakteriol Orig; 1966 Jun; 200(2):150-66. PubMed ID: 4296871
    [No Abstract]   [Full Text] [Related]  

  • 27. Investigation of some possibilities of producing type 3 vaccine poliovirus with greater genetic stability. I. Preliminary experiments with passage variants.
    Elbert LB; Chumakov MP; Krutyanskaya GL; Ralph NM; Tyufanov AV
    Acta Virol; 1968 May; 12(3):193-202. PubMed ID: 4385148
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on the mutagenic action of proflavine on type 3 poliovirus.
    Pervikov YV; Vorohsilova MK; Chumakov MP; Savinov AP; Yurovetskaya AL
    Acta Virol; 1973 Jul; 17(4):365. PubMed ID: 4148222
    [No Abstract]   [Full Text] [Related]  

  • 29. [Interference between measles and poliovirus in the monkey kidney cell culture].
    Weeke-Lüttmann M
    Zentralbl Bakteriol Orig; 1968; 209(1):10-5. PubMed ID: 4317772
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on safety tests of inactivated poliomyelitis vaccines. IV. Comparative safety tests in rhesus monkeys and long-tailed monkeys (Cercopithecus aethiops)].
    Günther O; Hövel H; von Mettenheim A; Burde K; Heber L; Unterharnscheidt F
    Zentralbl Bakteriol Orig; 1966 Jun; 200(2):137-50. PubMed ID: 4296870
    [No Abstract]   [Full Text] [Related]  

  • 31. Thousand litre scale microcarrier culture of Vero cells for killed polio virus vaccine. Promising results.
    Montagnon B; Vincent-Falquet JC; Fanget B
    Dev Biol Stand; 1983; 55():37-42. PubMed ID: 6677539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suspension-Vero cell cultures as a platform for viral vaccine production.
    Paillet C; Forno G; Kratje R; Etcheverrigaray M
    Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The choice of the cell substrate for human virus vaccine production.
    Hayflick L
    Lab Pract; 1970 Jan; 19(1):58-62. PubMed ID: 4984599
    [No Abstract]   [Full Text] [Related]  

  • 34. Replacement of serum by a soybean protein fraction in a basal tissue culture medium.
    Healy GM; Macmorine HG
    Prog Immunobiol Stand; 1971; 5():202-8. PubMed ID: 4349820
    [No Abstract]   [Full Text] [Related]  

  • 35. Replication of poliovirus (LSc 2 ab) in perfused cultures of MRC-5 diploid cells.
    Mann GF; de Mucha J
    Dev Biol Stand; 1976 Dec 13-15; 37():255-8. PubMed ID: 201522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A perfusion culture system for virus vaccine manufacture in diploid cell cultures.
    Mann GF; de Mucha Macías J
    Bull Pan Am Health Organ; 1976; 10(3):205-11. PubMed ID: 187274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of human virus vaccines in primary mammalian cells.
    Stones PB
    Lab Pract; 1970 Jan; 19(1):40-1 passim. PubMed ID: 4984598
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of 32 P labeled polioviruses, cultivated in different cell cultures, for chromatographic studies].
    Szöllösy E; Hils J; Böthig B
    Dtsch Gesundheitsw; 1969 Dec; 24(49):2333-7. PubMed ID: 4326148
    [No Abstract]   [Full Text] [Related]  

  • 39. [Agar culture of kidney cells of green African marmosets and the cytopathic effect].
    Levi MI
    Vopr Virusol; 1969; 14(1):111-4. PubMed ID: 4307613
    [No Abstract]   [Full Text] [Related]  

  • 40. [Production and characterization of some mouse embryo cellular substrates in vitro].
    Voiculescu C; Stoian I; Nachtigal S; Gaicu N; Duldurescu D; Palade V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1976; 21(2):111-20. PubMed ID: 183259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.